# Purple Biotech LTD.: Form 6-K, filed Feb 4, 2022

- Company: [Purple Biotech LTD.](/companies/ppbt.md) (CIK 1614744)
- Form: 6-K
- Filed: 2022-02-04
- Accepted by EDGAR: Feb 4, 2022, 08:31 ET
- Period: 2022-02-03
- Accession: 0001213900-22-005371
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1614744/000121390022005371/ea154898-6k_purplebio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1614744/000121390022005371/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1614744/000121390022005371/ea154898-6k_purplebio.htm

Filed Feb 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-005371. Last ingested by Listed: Nov 12, 2026, 22:01 ET. No prices; not investment advice.
